Elevance Health Inc. (ELV) Tops Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Elevance Health Reports Second Quarter 2022 Results, Raises Full Year Outlook
July 20, 2022 6:00 AM EDTSecond quarter GAAP net income was $6.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $8.04* per share. Operating revenue grew 15.6% over the prior year quarter to $38.5 billion. Operating gain grew 13.7% over the prior year quarter to $2.4 billion. Medical enrollment increased 2.7 million members year-over-year and 276 thousand members during the quarter to 47.1 million members. Third quarter 2022 dividend of $1.28 per share declared to shareholders.
INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health, Inc. (NYSE: ELV) reported second quarter 2022 results reflecting strong... More
